Evidence map›Paper›PMID 30987147›Full record

ArticleViruses2019

Interpreting Viral Deep Sequencing Data with GLUE.

Joshua B Singer, Emma C Thomson, Joseph Hughes, Elihu Aranday-Cortes, John McLauchlan, Ana da Silva Filipe, Lily Tong, Carmen F Manso, Robert J Gifford, David L Robertson and 6 more

Abstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Joshua B SingerMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. josh.singer@glasgow.ac.uk.ORCID 0000-0001-6989-475X
Emma C ThomsonMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Emma.Thomson@glasgow.ac.uk.ORCID 0000-0003-1482-0889
Joseph HughesMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. joseph.hughes@glasgow.ac.uk.ORCID 0000-0003-2556-2563
Elihu Aranday-CortesMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Elihu.Aranday-Cortes@glasgow.ac.uk.ORCID 0000-0003-2637-2307
John McLauchlanMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. John.McLauchlan@glasgow.ac.uk.ORCID 0000-0003-2217-9948
Ana da Silva FilipeMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Ana.daSilvaFilipe@glasgow.ac.uk.
Lily TongMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. lily.tong@glasgow.ac.uk.
Carmen F MansoVirus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. Carmen.Manso@phe.gov.uk.ORCID 0000-0001-6509-7163
Robert J GiffordMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. Robert.Gifford@glasgow.ac.uk.ORCID 0000-0003-4028-9884
David L RobertsonMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK. David.L.Robertson@glasgow.ac.uk.ORCID 0000-0001-6338-0221
Eleanor BarnesPeter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. ellie.barnes@ndm.ox.ac.uk.ORCID 0000-0002-0860-0831
M Azim AnsariPeter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. ansari@well.ox.ac.uk.ORCID 0000-0003-2790-8353
Jean L MbisaVirus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. Tamyo.Mbisa@phe.gov.uk.ORCID 0000-0002-0348-9679
David F BibbyVirus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. David.Bibby@phe.gov.uk.ORCID 0000-0002-8458-9662
Daniel BradshawVirus Reference Department, National Infection Service, Public Health England, Colindale, London NW9 5EQ, UK. Daniel.Bradshaw@phe.gov.uk.
David SmithPeter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. david.smith@stcatz.ox.ac.uk.ORCID 0000-0001-7778-7137

Funding

The Center for HIV RNA Studies (CRNA)U54GM103297 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TELESNITSKY, ALICE · 2017 to 2018
$10.2M
Medical Research Council MC_PC_16045Medical Research Council MC_PC_18048Medical Research Council MC_UU_12014/1Medical Research Council MC_UU_12014/12Medical Research Council MR/K01532X/1NIGMS NIH HHS U54 GM103297Wellcome Trust 102789/Z/13/Z
6 · The paper itself

Abstract

Using deep sequencing technologies such as Illumina's platform, it is possible to obtain reads from the viral RNA population revealing the viral genome diversity within a single host. A range of software tools and pipelines can transform raw deep sequencing reads into Sequence Alignment Mapping (SAM) files. We propose that interpretation tools should process these SAM files, directly translating individual reads to amino acids in order to extract statistics of interest such as the proportion of different amino acid residues at specific sites. This preserves per-read linkage between nucleotide variants at different positions within a codon location. The samReporter is a subsystem of the GLUE software toolkit which follows this direct read translation approach in its processing of SAM files. We test samReporter on a deep sequencing dataset obtained from a cohort of 241 UK HCV patients for whom prior treatment with direct-acting antivirals has failed; deep sequencing and resistance testing have been suggested to be of clinical use in this context. We compared the polymorphism interpretation results of the samReporter against an approach that does not preserve per-read linkage. We found that the samReporter was able to properly interpret the sequence data at resistance-associated locations in nine patients where the alternative approach was equivocal. In three cases, the samReporter confirmed that resistance or an atypical substitution was present at NS5A position 30. In three further cases, it confirmed that the sofosbuvir-resistant NS5B substitution S282T was absent. This suggests the direct read translation approach implemented is of value for interpreting viral deep sequencing data.

Indexed as

SoftwareAmino Acid SequenceAntiviral AgentsBase SequenceDrug Resistance, ViralGenome, ViralGenomicsHepacivirusHepatitis C, ChronicHigh-Throughput Nucleotide SequencingHumansMutationSequence AlignmentSequence Analysis, DNASofosbuvirViral Nonstructural ProteinsAntiviral AgentsSofosbuvirViral Nonstructural Proteinsbioinformaticsdeep sequencingdrug resistancehepatitis C virussequence interpretationvariant callingvirus genomics

Identifiers

PMID30987147
PMCPMC6520954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.